← Back to Clinical Trials
Recruiting NCT07655232

NCT07655232 Pilot Study of a Behavioral Program for Resident Depression in Skilled Nursing Facilities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07655232
Status Recruiting
Phase —
Sponsor Massachusetts General Hospital
Condition Nursing Home Resident
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-11-17
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Interventions for Stressful Transitions in Later Life (InSTILL) for Individuals

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-11-17 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL, for Individuals) for skilled nursing facility residents. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. Participants will join 6 bi-weekly sessions of the InSTILL program. Participants will complete assessments at three timepoints (all) and a brief-exit interview.

Eligibility Criteria

Inclusion Criteria: * Psychological distress, as indicated by a score Patient Health Questionnaire- 2 ≥ 2 OR Patient Health Questionnaire-9 ≥ 5 * 5+ chronic conditions based on Elixhauser Comorbidity Index * Aged ≥ 18 years * Able and willing to participate in the study Exclusion Criteria: * Intended length of SNF stay \< 7 days * More than mild cognitive impairment, as indicted by Brief Interview for Mental Status (BIMS) \<13 * Participant's roommate is already enrolled in study/intervention * High risk of suicide/active documented SI per the PHQ-9, item 9 or otherwise * Participation in newly initiated psychotherapy

Contact & Investigator

Central Contact

BRISK Study Coordinator

✉ brisk@mgb.org

📞 617-643-9406

Principal Investigator

Evan Plys, PhD

PRINCIPAL INVESTIGATOR

Massachusetts General Hospital

Frequently Asked Questions

Who can join the NCT07655232 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Nursing Home Resident. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07655232 currently recruiting?

Yes, NCT07655232 is actively recruiting participants. Contact the research team at brisk@mgb.org for enrollment information.

Where is the NCT07655232 trial being conducted?

This trial is being conducted at Boston, United States.

Who is sponsoring the NCT07655232 clinical trial?

NCT07655232 is sponsored by Massachusetts General Hospital. The principal investigator is Evan Plys, PhD at Massachusetts General Hospital. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology